Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treat

Discussion Board › Forums › New Developments › Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treat

Viewing 6 posts - 1 through 6 (of 6 total)
  • Author
    Posts
  • March 23, 2014 at 6:44 am #81000
    gavin
    Moderator

    Thanks for pointing that out Marion.

    Hugs back at you,

    Gavin

    March 22, 2014 at 8:35 am #80999
    marions
    Moderator

    Not sure, dear Gavin. The staging though is new:
    intrahepatic
    extrahepatic
    to:
    perihilar
    intrahepatic
    distal.
    From what I have learned is that the cell structure differs greatly and therapeutic drugs have different responses. Clinical research studies will stratify accordingly. We may find that these are different diseases.
    Hugs,
    Marion

    March 22, 2014 at 6:28 am #80998
    gavin
    Moderator

    And thanks for that as well Marion! This paper is from 2011 isn’t it?

    Hugs,

    Gavin

    March 21, 2014 at 9:11 pm #80997
    marions
    Moderator

    I don’t know how to interpret it, but assume that everything has to be validated by large scale clinical studies and those have not been conducted. Therefore, the comment: There is no evidence that regular follow…… I will try to find an answer to your question and will post if and when I receive a response.
    Hugs,
    Marion

    March 21, 2014 at 8:16 pm #80996
    wallsm1
    Spectator

    Interesting. It is noted on here that follow up post resection does not effect outcomes. Does that mean they don’t recommend routine imaging post resection?

    March 21, 2014 at 5:11 pm #9705
    marions
    Moderator

    http://annonc.oxfordjournals.org/content/22/suppl_6/vi40.full

    Note: staging for CCA
    intrahepatic
    perihilar
    distal

  • Author
    Posts
Viewing 6 posts - 1 through 6 (of 6 total)
  • The forum ‘New Developments’ is closed to new topics and replies.